Australia markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
61.43-2.34 (-3.67%)
At close: 04:00PM EDT
61.43 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate0.961.094.494.99
Low estimate0.881.034.34.52
High estimate1.041.144.625.34
Year ago EPS1.281.274.714.49
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate129.53M135.22M515.12M578.63M
Low estimate125.9M134.4M403M566.08M
High estimate134.78M136.84M550.73M586.09M
Year ago sales116.55M131.83M486.82M515.12M
Sales growth (year/est)11.10%2.60%5.80%12.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.680.840.851
Actual EPS1.281.2711.21
Difference0.60.430.150.21
Surprise %88.20%51.20%17.60%21.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.961.094.494.99
7 days ago1.081.174.485.02
30 days ago1.071.174.475.04
60 days ago1.071.174.475.04
90 days ago1.091.144.295.01
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A21
Up last 30 daysN/AN/A21
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5533
Growth estimatesANIPIndustrySector(s)S&P 500
Current qtr.-25.00%N/AN/AN/A
Next qtr.-14.20%N/AN/AN/A
Current year-4.70%N/AN/AN/A
Next year11.10%N/AN/AN/A
Next 5 years (per annum)2.20%N/AN/AN/A
Past 5 years (per annum)-4.61%N/AN/AN/A